AIDS Related Primary CNS Lymphoma Market Segments, Opportunity, Growth and Forecast by End-use Industry 2016-2026
Acquired immunodeficiency syndrome (AIDS) is a viral disease of immune system caused by the infection of human immunodeficiency virus (HIV). Primary central nervous system lymphoma (PCNSL) is a primary intracranial tumor occurs mostly in patients suffering from severe immunosuppression specifically AIDS. The pathogen responsible for primary CNS lymphoma is Epstein-Barr virus. AIDS associated primary CNS lymphoma diffuses large-cell lymphoma of B-cell which usually occurs in brain or spinal cord. Patients suffering from CNS lymphoma complain about lethargy, headache, neurologic symptoms and signs and changes in mental status. For diagnosing AIDS associated primary CNS lymphoma, Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) is performed. Biopsy diagnosis is also performed to confirm the results as the lesions reported in MRI and CT scan sometimes generate confusion between toxoplasmosis, progressive multifocal leukoencephalopathy (PML) lesions and lymphoma.
Acquired immunodeficiency syndrome (AIDS) is a viral disease of immune system caused by the infection of human immunodeficiency virus (HIV). Primary central nervous system lymphoma (PCNSL) is a primary intracranial tumor occurs mostly in patients suffering from severe immunosuppression specifically AIDS. The pathogen responsible for primary CNS lymphoma is Epstein-Barr virus. AIDS associated primary CNS lymphoma diffuses large-cell lymphoma of B-cell which usually occurs in brain or spinal cord. Patients suffering from CNS lymphoma complain about lethargy, headache, neurologic symptoms and signs and changes in mental status. For diagnosing AIDS associated primary CNS lymphoma, Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) is performed. Biopsy diagnosis is also performed to confirm the results as the lesions reported in MRI and CT scan sometimes generate confusion between toxoplasmosis, progressive multifocal leukoencephalopathy (PML) lesions and lymphoma.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>AIDS</strong> <strong>Related</strong> <strong>Primary</strong><br />
<strong>CNS</strong> <strong>Lymphoma</strong> <strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> <strong>Forecast</strong>,<br />
<strong>2016</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive <strong>and</strong> Transportation<br />
• Electronics, Semiconductor, <strong>and</strong> ICT<br />
• Retail <strong>and</strong> Consumer Products<br />
• Industrial Automation <strong>and</strong> Equipment<br />
• Chemicals & Materials<br />
• Food <strong>and</strong> Beverages<br />
• Services <strong>and</strong> Utilities<br />
• Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
Acquired immunodeficiency syndrome (<strong>AIDS</strong>) is a viral disease of immune system ca<strong>use</strong>d<br />
<strong>by</strong> the infection of human immunodeficiency virus (HIV). <strong>Primary</strong> central nervous system<br />
lymphoma (P<strong>CNS</strong>L) is a primary intracranial tumor occurs mostly in patients suffering<br />
from severe immunosuppression specifically <strong>AIDS</strong>. The pathogen responsible for primary<br />
<strong>CNS</strong> lymphoma is Epstein-Barr virus. <strong>AIDS</strong> associated primary <strong>CNS</strong> lymphoma diff<strong>use</strong>s<br />
large-cell lymphoma of B-cell which usually occurs in brain or spinal cord. Patients<br />
suffering from <strong>CNS</strong> lymphoma complain about lethargy, headache, neurologic symptoms<br />
<strong>and</strong> signs <strong>and</strong> changes in mental status. For diagnosing <strong>AIDS</strong> associated primary <strong>CNS</strong><br />
lymphoma, Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) is<br />
performed. Biopsy diagnosis is also performed to confirm the results as the lesions<br />
reported in MRI <strong>and</strong> CT scan sometimes generate confusion between toxoplasmosis,<br />
progressive multifocal leukoencephalopathy (PML) lesions <strong>and</strong> lymphoma.<br />
<strong>AIDS</strong> - <strong>Related</strong> <strong>Primary</strong> <strong>CNS</strong> <strong>Lymphoma</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restraints<br />
The market is expected to witness high growth during the forecast period as number of<br />
<strong>AIDS</strong> patients are increasing across the globe. Likewise, increasing awareness initiatives<br />
<strong>by</strong> government authorities would propel the growth of <strong>AIDS</strong> - related primary <strong>CNS</strong><br />
lymphoma market. Also, many pharmaceutical companies are entering into market for<br />
developing <strong>and</strong> manufacturing drugs for preventing <strong>and</strong> treating <strong>AIDS</strong>- related primary<br />
<strong>CNS</strong> lymphoma.<br />
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1400
Report Description<br />
<strong>AIDS</strong> - <strong>Related</strong> <strong>Primary</strong> <strong>CNS</strong> <strong>Lymphoma</strong> <strong>Market</strong>: Segmentation<br />
<strong>AIDS</strong> - related primary <strong>CNS</strong> lymphoma market is classified on the basis of drug type,<br />
distribution channel <strong>and</strong> geography.<br />
Based on the drug type, the global market for <strong>AIDS</strong> - related primary <strong>CNS</strong> lymphoma is<br />
segmented into the following:<br />
• Methotrexate<br />
• Thiotepa<br />
• Procarbazine<br />
• Temozolomide<br />
Based on the distribution channel the global market for <strong>AIDS</strong> - related primary <strong>CNS</strong><br />
lymphoma is segmented into the following:<br />
• Hospitals Clinics<br />
• Private Clinics<br />
• Retail Pharmacies <strong>and</strong> Drug Stores<br />
• e-commerce
Report Description<br />
Based on the geography the global market for <strong>AIDS</strong> - related primary <strong>CNS</strong> lymphoma is<br />
segmented into the following:<br />
• North America<br />
• Latin America<br />
• Western Europe<br />
• Eastern Europe<br />
• Asia Pacific<br />
• Japan<br />
• Middle East <strong>and</strong> Africa<br />
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1400<br />
<strong>AIDS</strong> - <strong>Related</strong> <strong>Primary</strong> <strong>CNS</strong> <strong>Lymphoma</strong> <strong>Market</strong>: Overview<br />
Chemotherapy <strong>and</strong> radiation therapy are administered for treatment of <strong>AIDS</strong> - related<br />
primary <strong>CNS</strong> lymphoma. <strong>AIDS</strong> - related primary <strong>CNS</strong> lymphoma. Various drugs have been<br />
utilized during chemotherapy sessions include methotrexate, thiotepa <strong>and</strong> procarbazine.<br />
For increasing treatment efficiency, rituximab is combined with methotrexate.<br />
Temozolomide is also <strong>use</strong>d with those patients who demonstrate fair response to the<br />
treatment.
Report Description<br />
<strong>AIDS</strong> - <strong>Related</strong> <strong>Primary</strong> <strong>CNS</strong> <strong>Lymphoma</strong> <strong>Market</strong>: Region-wise Outlook<br />
Depending on geographic regions, global <strong>AIDS</strong> - related primary <strong>CNS</strong> lymphoma market is<br />
segmented into seven key regions: North America, Latin America, Eastern Europe,<br />
Western Europe, Asia Pacific Excluding Japan, Japan <strong>and</strong> Middle East & Africa. North<br />
America <strong>and</strong> Eastern Europe markets are currently at the maturity stage for clinical<br />
research <strong>and</strong> methods for treating <strong>AIDS</strong> associated primary <strong>CNS</strong> lymphoma due to their<br />
position to <strong>use</strong> expensive drugs <strong>and</strong> treatment. However, Asia-Pacific market looks<br />
attractive for <strong>AIDS</strong> associated primary <strong>CNS</strong> lymphoma treatment owing to increasing<br />
awareness among the people about the treatment availability. Considering the treatment<br />
types, HAART occupies the major market share among the other available treatments.<br />
The institutes which are majorly involved in clinical research for <strong>AIDS</strong> associated primary<br />
<strong>CNS</strong> lymphoma treatments are the National Cancer Institute, National Institute of Allergy<br />
<strong>and</strong> Infectious diseases, <strong>AIDS</strong> Malignancy Clinical Trials Consortium, European<br />
Organization for Research <strong>and</strong> Treatment of Cancer <strong>and</strong> Eastern Cooperative Oncology<br />
Group.<br />
Browse full report: http://www.futuremarketinsights.com/reports/aids-related-primarycns-lymphoma-market<br />
<strong>AIDS</strong> - <strong>Related</strong> <strong>Primary</strong> <strong>CNS</strong> <strong>Lymphoma</strong> <strong>Market</strong>: Key Players<br />
Some of the key players in global <strong>AIDS</strong> - related primary <strong>CNS</strong> lymphoma market are<br />
Fresenius SE & Co. KGaA, Amgen Inc., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Celon<br />
Laboratories Limited among several others.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For other queries contact: Mr. Sudip Saha<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language